Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Logicalis

Logicalis is an international IT solutions and managed services provider with a breadth of knowledge and expertise in communications and collaboration; business analytics; data centre and cloud services; and managed services. Logicalis employs almost 3,000 people worldwide, including highly trained service specialists who design, specify, deploy and manage complex ICT infrastructures to meet the needs of over 6,000 corporate and public sector customers.  To achieve this, Logicalis maintains strong partnerships with technology leaders such as Cisco, HP, IBM, CA Technologies, NetApp, VMware and ServiceNow.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

Logicalis
110 Buckingham Avenue, Slough, Berkshire, SL1 4PF, UK
+44 (0)1753 777200
Contact Logicalis
Website

 Latest Content from PMHub 

The Social Dilemma

Press Releases | June 19, 2019 | Lucid Group Communications Limited

In the June issue of PME, Dennis O’Brien, Lucid CEO, explores the relationship between social media and pharma.“There is a party going on next door, but our industry is too...

A postcard from Cannes

Press Releases | June 19, 2019 | Resonant Group

This week sees the annual Cannes Lions International Festival of Creativity, bringing together leading creative talent from across the globe to learn, share and inspire each other. Until recently, pharmaceuticals...

Lucid Group Let Loose with the Launch of ‘Summer Fridays’

Press Releases | June 19, 2019 | Lucid Group Communications Limited

In-line with Lucid’s agile working policy, the company is introducing the concept of ‘Summer Fridays’ across all of its UK businesses in July and August.A ‘Summer Friday’ means that employees...

Webinar: Usability and UX: You’ve been asked to test…What next?

White Papers and Resources | June 18, 2019 | Inizio

Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST

Event: EphMRA Annual Conference

White Papers and Resources | June 18, 2019 | Inizio

We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland.

Research Partnership and Janssen awarded runner-up in MR Excellence Awards

White Papers and Resources | June 18, 2019 | Inizio

We are delighted to announce that an entry by Janssen and Research Partnership for the 2019 EphMRA MR Excellence Awards has been awarded runner-up in the ‘Business Impact through Innovation’...

Lucid demonstrates continual investment in its central services with the appointment of its new Head of Talent, Resourcing and HR projects

Press Releases | June 14, 2019 | Lucid Group Communications Limited

Lucid group is excited to announce the appointment of its new head of Talent, Resourcing and HR projects, Olivia Emirali.Olivia joined Lucid in March this year to review recruitment and...

Fake News is Bad for your Health

White Papers and Resources | June 14, 2019 | Life Healthcare Communications

Ill informed patients make poor health decisions

Secrets of Pharma Advertising

White Papers and Resources | June 14, 2019 | Life Healthcare Communications

If the goal of branding is to be different, why do so many Pharma brand ads look the same?

Precision medicine with precision management and precision pricing; ensuring affordability in the cell and gene therapy era

White Papers and Resources | June 12, 2019 | OPEN Health

The third plenary session at ISPOR in New Orleans focused on affordability in the face of new and expensive therapies and asked the question “is affordability driving a need to...